NDC 33261-671 Primaquine Phosphate

View Dosage, Usage, Ingredients, Routes, UNII

Product Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.
NDC Product Code:
33261-671
Proprietary Name:
Primaquine Phosphate
Product Type: [3]
INACTIVATED PRODUCT and EXCLUDED the from NDC Directory
Labeler Code:
33261
Start Marketing Date: [9]
08-01-2014
Listing Expiration Date: [11]
12-31-2019
Exclude Flag: [12]
I
Code Navigator:

Product Characteristics

Color(s):
PURPLE (C48327)
Shape:
ROUND (C48348)
Size(s):
8 MM
Imprint(s):
BY4
Score:
1

Code Structure Chart

Product Details

What is NDC 33261-671?

The NDC code 33261-671 is assigned by the FDA to the product Primaquine Phosphate which is product labeled by Aidarex Pharmaceuticals Llc. The product's dosage form is . The product is distributed in 3 packages with assigned NDC codes 33261-671-00 100 tablet in 1 bottle , 33261-671-14 14 tablet in 1 bottle , 33261-671-28 28 tablet in 1 bottle . This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

What are the uses for Primaquine Phosphate?

Primaquine phosphate is indicated for the radical cure (prevention of relapse) of vivax malaria.

Which are Primaquine Phosphate UNII Codes?

The UNII codes for the active ingredients in this product are:

Which are Primaquine Phosphate Inactive Ingredients UNII Codes?

The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

What is the NDC to RxNorm Crosswalk for Primaquine Phosphate?

RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:
  • RxCUI: 904170 - primaquine phosphate 26.3 MG Oral Tablet
  • RxCUI: 904170 - primaquine phosphate 26.3 MG (primaquine 15 MG) Oral Tablet

* Please review the disclaimer below.

Patient Education

Primaquine


Primaquine is used alone or with another medication to treat malaria (a serious infection that is spread by mosquitoes in certain parts of the world and can cause death) and to prevent the disease from coming back in people that are infected with malaria. Primaquine is in a class of medications called antimalarials. It works by killing the organisms that cause malaria.
[Learn More]


* Please review the disclaimer below.

Product Footnotes

[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.

[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".